Sjögren and Gynecologic Considerations

CompletedOBSERVATIONAL
Enrollment

118

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

October 15, 2022

Study Completion Date

November 10, 2022

Conditions
Primary Sjögren SyndromeVaginitis CandidaVaginitisSexual Dysfunction
Interventions
OTHER

Visual analogue scale (VAS) for dyspareunia

Dyspareunia scores between 0 to 10 points

OTHER

Visual analogue scale (VAS) for vaginal dryness

Vaginal dryness scores between 0 to 10 points

OTHER

The European League Against Rheumatism Sjögren's Syndrome Disease Activity Index (ESSDAI)

Sjögren's Syndrome Disease Activity Index scores between 0 to 3 points

OTHER

The European League Against Rheumatism Sjögren's Syndrome Patient Reported Index (ESSPRI)

Sjögren's Syndrome Patient Reported Index scores between 0 to 10 points

Trial Locations (1)

06100

Ankara City Hospital, Ankara

All Listed Sponsors
lead

Ankara City Hospital Bilkent

OTHER

NCT05670535 - Sjögren and Gynecologic Considerations | Biotech Hunter | Biotech Hunter